Affiliation:
1. Department of Medical Science, Institute of Congenital Metabolic Diseases, Paracelsus Medical University, 5020 Salzburg, Austria
2. Department of Rare Diseases, European Reference Network for Hereditary Metabolic Diseases, MetabERN, 33100 Udine, Italy
Abstract
Mucopolysaccharidoses (MPS) are a group of rare, heterogeneous, lysosomal storage disorders. Patients show a broad spectrum of clinical features with a substantial unmet medical need. Individual treatment trials (ITTs) might be a valid, time- and cost-efficient way to facilitate personalized medicine in the sense of drug repurposing in MPS. However, this treatment option has so far hardly been used—at least hardly been reported or published. Therefore, we aimed to investigate the awareness and utilization of ITTs among MPS clinicians, as well as the potential challenges and innovative approaches to overcome key hurdles, by using an international expert survey on ITTs, namely, ESITT. Although 74% (20/27) were familiar with the concept of ITTs, only 37% (10/27) ever used it, and subsequently only 15% (2/16) published their results. The indicated hurdles of ITTs in MPS were mainly the lack of time and know-how. An evidence-based tool, which provides resources and expertise needed for high-quality ITTs, was highly appreciated by the vast majority (89%; 23/26). The ESITT highlights a serious deficiency of ITT implementation in MPS—a promising option to improve its treatability. Furthermore, we discuss the challenges and innovative approaches to overcome key barriers to ITTs in MPS.
Subject
Drug Discovery,Pharmaceutical Science,Molecular Medicine
Reference50 articles.
1. Epidemiology of mucopolysaccharidoses;Khan;Mol. Genet. Metab.,2017
2. Sawamoto, K., Álvarez González, J.V., Piechnik, M., Otero, F.J., Couce, M.L., Suzuki, Y., and Tomatsu, S. (2020). Mucopolysaccharidosis IVA: Diagnosis, Treatment, and Management. Int. J. Mol. Sci., 21.
3. Mucopolysaccharidosis: Clinical features, diagnosis and management;Rev. Chil. Pediatr.,2016
4. David Valle, M. (2001). The Metabolic and Molecular Bases of Inherited Disease, OMMBID, McGrawHill Medical. [8th ed.].
5. Lysosomal storage disease overview;Sun;Ann. Transl. Med.,2018
Cited by
2 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献